At a glance
ClinicalIndex Comparison RecordN/AActive· 50 target
Drug / intervention
Northern Light Technology (SADelite lamp) bright light-therapy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NCT00590265N/AActiveUpdate OverdueUpdated 22mo ago · Completion was 13mo agoEnrollment Stalled
Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression: Double-Blind, Placebo-Controlled Study to Establish Efficacy and Safety
In Brief
A clinical study evaluating Northern Light Technology (SADelite lamp) bright light-therapy and Northern Light Technology (SADelite lamp) Dim light-therapy for Bipolar Type II Disorder and Depression, Bipolar. Active but no longer recruiting, targeting 50 participants across 1 site.
Signals
Enrollment appears stalled
Detailed Summary
The purpose of this study is to evaluate the efficacy and safety of light therapy for the treatment of bipolar type II patients relapsing into a depressive phase during autumn or winter.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Type II Disorder, Depression, Bipolar
CountriesCanada
Timeline
N/AActive
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
First PostedJan 2008
Primary CompletionJun 2025
TodayJul 2026
Study CompletionAug 2026
First PostedJan 10, 2008
Enrollment StartJan 1, 2008
Primary CompletionJun 1, 2025
Study CompletionAug 1, 2026
TodayJul 2, 2026
Enrollment to primary: 17.4 yearsPosted 18.5 years ago
Interventions
Northern Light Technology (SADelite lamp) bright light-therapydevice
10 000 lux for 30 minutes
Northern Light Technology (SADelite lamp) Dim light-therapydevice
\<100 lux for 30 minutes